AU2003215369A1 - Intracellular signaling molecules - Google Patents

Intracellular signaling molecules

Info

Publication number: AU2003215369A1
Authority: AU; Australia
Prior art keywords: intracellular signaling; signaling molecules; molecules; intracellular; signaling
Prior art date: 2002-02-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003215369A

Other versions

AU2003215369A8 (en

Inventor

Olga Bandman

Ines Barroso

Mariah R. Baughn

Shanya D. Becha

Sean A. Bulloch

Neil Burford

Narinder K. Chawla

Vicki S. Elliott

Brooke M. Emerling

Ian J. Forsythe

Kimberly J. Gietzen

Jennifer A. Griffin

April J.A. Hafalia

Phillip R. Hawkins

Pei Jin

Amy E. Kable

Reena Khare

Ernestine A. Lee

Sally Lee

Soo Yeun Lee

Patricia M. Lehr-Mason

Joana X. Li

Joseph P. Marquis

Jayalaxmi Ramkumar

Thomas W. Richardson

Anita Swarnakar

Y. Tom Tang

Bridget A. Warren

Monique G. Yao

Henry Yue

Yeganeh Zebarjadian

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Incyte Corp

Original Assignee

Incyte Genomics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-22

Filing date

2003-02-19

Publication date

2003-09-09

2003-02-19 Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc

2003-09-09 Publication of AU2003215369A8 publication Critical patent/AU2003215369A8/en

2003-09-09 Publication of AU2003215369A1 publication Critical patent/AU2003215369A1/en

Status Abandoned legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Analytical Chemistry (AREA)
Toxicology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Tropical Medicine & Parasitology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU2003215369A 2002-02-22 2003-02-19 Intracellular signaling molecules Abandoned AU2003215369A1 (en)

Applications Claiming Priority (13)

Application Number	Priority Date	Filing Date	Title
US35941302P	2002-02-22	2002-02-22
US60/359,413		2002-02-22
US36117602P	2002-03-01	2002-03-01
US60/361,176		2002-03-01
US37249902P	2002-04-12	2002-04-12
US60/372,499		2002-04-12
US37986202P	2002-05-10	2002-05-10
US60/379,862		2002-05-10
US38196402P	2002-05-16	2002-05-16
US60/381,964		2002-05-16
US38443902P	2002-05-31	2002-05-31
US60/384,439		2002-05-31
PCT/US2003/005336 WO2003072723A2 (en)	2002-02-22	2003-02-19	Intracellular signaling molecules

Publications (2)

Publication Number	Publication Date
AU2003215369A8 AU2003215369A8 (en)	2003-09-09
AU2003215369A1 true AU2003215369A1 (en)	2003-09-09

Family

ID=27767975

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003215369A Abandoned AU2003215369A1 (en)	2002-02-22	2003-02-19	Intracellular signaling molecules

Country Status (2)

Country	Link
AU (1)	AU2003215369A1 (en)
WO (1)	WO2003072723A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003901055A0 (en) *	2003-02-17	2003-03-20	Nathan E Hall	Methods for inhibiting signal transduction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002020756A2 (en) *	2000-09-05	2002-03-14	Incyte Genomics, Inc.	Secretory molecules

2003
- 2003-02-19 AU AU2003215369A patent/AU2003215369A1/en not_active Abandoned
- 2003-02-19 WO PCT/US2003/005336 patent/WO2003072723A2/en not_active Ceased

Also Published As

Publication number	Publication date
AU2003215369A8 (en)	2003-09-09
WO2003072723A3 (en)	2005-02-10
WO2003072723A2 (en)	2003-09-04

Publication	Publication Date	Title
AU2003255831A1 (en)	2004-03-19	Delayed-gelation solution
AU2003272930A1 (en)	2005-01-04	Footwere
AU2003262380A1 (en)	2003-11-03	Signaling assembly
AU2002359242A1 (en)	2003-04-22	Intracellular signaling molecules
AU2002365195A1 (en)	2003-07-30	Intracellular signaling molecules
EP1572168A3 (en)	2005-09-22	Anti-infarction molecules
AU2003274573A1 (en)	2004-09-28	Deburrer
AU2002305861A1 (en)	2002-12-23	Intracellular signaling molecules
AU5619100A (en)	2001-01-02	Intracellular signaling molecules
AU2002350174A1 (en)	2003-05-19	Intracellular signaling molecules
AU2003237841A1 (en)	2004-01-19	Pain signaling molecules
AU2003304540A1 (en)	2004-06-06	Illuminator
AU2002216625A1 (en)	2002-04-22	Intracellular signaling molecules
AU2003215369A1 (en)	2003-09-09	Intracellular signaling molecules
AU2003234859A1 (en)	2004-09-17	Description
AU2002245408A1 (en)	2002-08-19	Intracellular signaling molecules
AU2003241210A1 (en)	2004-08-13	Videocomputer
AU2003251590A1 (en)	2004-01-06	Intracellular signaling proteins
AU2001297540A1 (en)	2002-10-08	Intracellular signaling molecules
AU2004100040A4 (en)	2004-03-11	Securing block
AU2003273564A1 (en)	2003-12-19	Drinking flask
AU2003100006A4 (en)	2003-07-17	Adcaster
AU2003100198A4 (en)	2003-07-10	Colourband Browbands
AU2003100325A4 (en)	2003-07-10	Freez-A-Cube
AU2003100378A4 (en)	2003-08-07	Scootermansydney

Legal Events

Date	Code	Title	Description
2004-11-11	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase